Clinical guidelines on identification, management and complications of chronic kidney disease;Sociedad Chilena de Nefrología Enfermedad renal crónica: Clasificación, identificación, manejo y complicaciones

Revista Medica de Chile

Volumn 137, Issue 1, 2009, Pages 137-177

  Flores, Juan C ^a,b   Alvo, Miriam ^a,c   Borja, Hernán ^a,d   Morales, Jorge ^a,e   Vega, Jorge ^a,f   Zúñiga, Carlos ^a,g   Müller, Hans ^a,g   Münzenmayer, Jorge ^a,h  

^a Comité de Salud Renal y Guías Clínicas ^*

^b Hospital Militar

^c HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^d Hospital Dr Gustavo Fricke   (Chile)

^e CLÍNICA LAS CONDES   (Chile)

^f HOSPITAL NAVAL ALMIRANTE NEF   (Chile)

^g UNIVERSIDAD CATÓLICA DE LA SANTÍSIMA CONCEPCIÓN   (Chile)

^h UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

Diabetic nephropathy; Hypertension; Public health

Indexed keywords

ALBUMINURIA; ARTICLE; CHILE; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; HEMATURIA; HUMAN; HYPERTENSION; KIDNEY FUNCTION TEST; PRACTICE GUIDELINE; PROTEINURIA;

ALBUMINURIA; CHILE; DIABETES COMPLICATIONS; HEMATURIA; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; PROTEINURIA;

EID: 65849353600     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. NATIONAL KIDNEY FOUNDATION. K/DOQI Clinical Practice Guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39 (Supply 1): S1-S266.
2. U.S. RENAL DATA SYSTEM, USRDS 2007 ANNUAL DATE REPORT: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2007.
3. CORESH J, BYRD-HOLT D, ASTOR B, BRIGGS J, EGGERS P, LACHER D ET AL. Chronic kidney disease awareness, prevalence and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005; 16: 180-188.
4. ENCUESTA NACIONAL DE SALUD, CHILE 2003. Disponible en página web Minsal: http://epi.minsal.cl/epi/html/invest/ENS/ENS.htm
5. Mezzano S, Aros C. Enfermedad renal crónica: clasificación, mecanismos de progresión y estrategias de renoprotección. Rev Méd Chile 2005; 133: 338-48.
6. GO AS, CHERTOW GM, FAN D, MC CULLOCH C, HSU C. Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Engl J Med 2004; 351: 1296-305.
7. KEITH D, NICHOLS G, GULLION C, BROWN JB, SMITH D. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-63.
8. ZIMMET P, ALBERTI K, SHAW J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7.
9. KEARNEY P, WHELTON B, REYNOLDS K, MUNTNER P, WHELTON P, HE J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-23.
10. POORTMAN J, JEANLOZ RW. Quantitative immunological determination of plasma proteins excreted in human urine collected before and after exercise. J Clin Invest 1968; 47: 386-93.
11. ROBINSON R. Isolated proteinuria in asymptomatic patients. Kidney Int 1980; 18: 395-406.
12. GRIMM RH, SVENDSEN KH, KASISKE B, KEANE WF, WAHI MM. Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Kidney Int 1997; 63 (suppl): S10-S14.
13. PEGG JF, REINHARDT RW, O'BRIEN JM. Proteinuria in adolescent sports physical examinations. J Fam Pract 1986; 22: 80-1.
14. WOOLHANDLER S, PELS RJ, BOR DH, HIMMELSTEIN DU, LAWRENCE RS. Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders. 1. Hematuria and proteinuria. JAMA 1989; 262: 1214-19.
15. BOULWARE LE, JAAR B, TARVER-CARR M, BRANCATI F, POWE N. Screening for proteinuria in US adults: A costeffectiveness analysis. JAMA 2003; 290: 3101-14.
16. EKNOYAN G. On testing for proteinuria: Time for a methodical approach. Cleve Clin J Med 2003; 70: 493, 496-7, 501.
17. AMERICAN DIABETES ASSOCIATION. Nephropathy in Diabetes. Diabetes Care 2004; 27 (Suppl 1): S79-S83.
18. KHOSLA N, SARAFIDIS PA, BAKRIS GL. Microalbuminuria. Clin Lab Med 2006; 26: 635-53.
19. VIBERTI GC, HILL RD, JARRETT RJ, ARGYROPOULOS A, MAHMUD U, KEEN H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1: 1430-2.
20. JONES CA, FRANCIS M, EBERHARDT M, CHAVERS B, CORESH J, ENGELGAU M ET AL. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002; 39: 445-59.
21. BUSBY DE, BAKRIS GL. Comparison of commonly used assays for the detection of microalbuminuria. J Clin Hypertens (Greenwich) 2004; 6(11) (Suppl 3): 8-12.
22. GROSSFELD GD, WOLF JS, LITWIN MS, SHULER CL, AGERTER DC ET AL. Asymptomatic microscopic hematuria in adults: Summary of the AUA best practice recommendations. Am Fam Physician 2001; 63: 1145-54.
23. COHEN RA, BROWN RS. Microscopic Hematuria. N Engl J Med 2003; 348: 2330-8.
24. YUN EJ, MAXWELL VM, CARROLL PR. Evaluation of the patient with hematuria. Med Clin N Am 2004; 88: 329-43.
25. MCDONALD M, SWAGERTY D, WETZEL L. Assessment of microscopic hematuria. Am Fam Physician 2006; 73: 1748-54.
26. TRAYNOR J, MACTIER R, GEDDES CC, FOX JG. How to measure renal function in clinical practice. BMJ 2006; 333: 733-7.
27. STEVENS LA, CORESH J, GREENE T, LEVEY A. Assessing kidney function - Measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473-83.
28. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
29. LEVEY AS, BOSCH JP, LEWIS JB, GREENE T, ROGERS N, ROTH D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-70.
30. CORESH J, STEVENS LA. Kidney function estimating equations: where do we stand?. Curr Opin Nephrol Hypertens 2006; 15: 276-84.
31. NATIONAL KIDNEY DISEASE EDUCATION PROGRAM: Suggestions for Laboratories. www.nkdep.nih.gov/labprofessionals
32. CHOBANIAN AV, BAKRIS GL, BLACK HR, CUSHMAN WC, GREEN LA, IZZO JL ET AL. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 2003; 289: 2560-72.
33. MANCIA G, DE BACKER G, DOMINICZAK A, CIFKOVA R, FAGARD R, GERMANO G ET AL. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension 2007; 25: 1105-87.
34. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007; 49 (Supply 2): S1-S179.
35. AMERICAN DIABETES ASSOCIATION. Standards of medical care in Diabetes-2008. Diabetes Care 2008; 31 (Supply 1): S12-S54.
36. AMERICAN DIABETES ASSOCIATION. Treatment of hypertension in adults with diabetes. Diabetes Care 2003 26 (Supply 1): S80-S82.
37. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43 (Supply1): S1-S290.
38. KLAHR S, LEVEY A, BECK G, CAGGIULA A, HUNSICKER L, KUSEK J ET AL. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 1994; 330: 877-884.
39. SHEP COOPERATIVE RESEARCH GROUP. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-64.
40. OSTCHEGA Y, DILLON CF, HUGHES JP, CARROLL M, YOON S. Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc 2007; 55: 1056-65.
41. FRANKLIN S, GUSTIN W, WONG ND, LARSON MG, WEBER MA, KANNEL WB ET AL. Hemodynamic patterns of agerelated changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96: 308-315.
42. THE ALLHAT OFFICERS AND COORDINATORS FOR THE ALLHAT COLLABORATIVE RESEARCH GROUP. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering treatment toprevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981-97
43. WING LM, REID CM, RYAN P, BEILIN LJ, BROWN MA, JENNINGS GL ET AL. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003; 348: 583-92.
44. STAESSEN JA, FAGARD R, THIJS L, CELIS H, ARABIDZE GG, BIRKENHAGER WH ET AL. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-64.
45. NATIONAL KIDNEY FOUNDATION. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006; 47 (Suppl. 3): S1-S145.
46. EBPG II WORKING GROUP. Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 2004; 19 (Suppl. 2): 1-47.
47. OBRADOR G, RUTHAZER R, ARORA P, KAUSZ AT, PEREIRA B. Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol 1999; 10: 1793-800.
48. FOLEY RN, PARFREY PS, HARNETT JD, KENT GM, MURRAY DC, BARRE PE. The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease. Am J Kidney Dis 1996; 28: 53-61.
49. MOE S, DRÜEKE T, CUNNINGHAM J, GOODMAN W, MARTIN K, OLGAARD K ET AL. Definition, evaluation, and classification of renal osteodystrophy: A position statement fro Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69: 1945-53.
50. LEVIN A, BAKRIS GL, MOLITCH M, SMULDERS M, TIAN J, WILLIAMS LA ET AL. Prevalence of abnormal serum vitamin D, PTH, calcium and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007; 71: 31-8.
51. MARTIN K, OLGAARD K. Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis 2004; 43: 558-65.
52. BLOCK GA, KLASSEN PS, LAZARUS JM, OFSTHUN N, LOWRIE EG, CHERTOW GM. Mineral metabolism, mortality, and morbidity in maintenence hemodialysis. J Am Soc Nephrol 2004; 15: 2208-18.
53. NATIONAL KIDNEY FOUNDATION. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42 (Supply 3): S1-S201.
54. KINCHEN KS, SADLER J, FINK N, BROOKMEYER R, KLAG MJ, LEVEY AS ET AL. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 2002; 137: 479-86.